These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35981776)

  • 1. Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models.
    Elek P; Csanádi M; Fadgyas-Freyler P; Gervai N; Oross-Bécsi R; Szécsényi-Nagy B; Tatár M; Váradi B; Zemplényi A
    BMJ Open; 2022 Aug; 12(8):e061941. PubMed ID: 35981776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
    Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
    Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statewide Examination of Access to Cancer Surgery During the COVID-19 Pandemic.
    Adams EJ; Feinglass JM; Hae-Soo Joung R; Odell DD
    J Surg Res; 2023 Jun; 286():8-15. PubMed ID: 36724572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.
    Gálffy G; Szabó GT; Tamási L; Müller V; Moldvay J; Sárosi V; Kerpel-Fronius A; Kardos T; Csada E; Pápai-Székely Z; Szász Z; Király Z; Hódi G; Kovács Z; Balogh É; Kovács KA; Darida M; Buga V; Rokszin G; Abonyi-Tóth Z; Kiss Z; Vokó Z; Bogos K
    Pathol Oncol Res; 2024; 30():1611754. PubMed ID: 38887697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of coronavirus disease 2019 on the number of newly diagnosed cancer patients and examinations and surgeries performed for cancer in Japan: a nationwide study.
    Terashima T; Konishi H; Sato Y; Igarashi M; Yanagibashi T; Konno R; Saya H; Doki Y; Kakizoe T
    BMC Cancer; 2022 Dec; 22(1):1303. PubMed ID: 36514005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay and Disparity in Observed vs Predicted Incidence Rate of Screenable Cancer During the COVID-19 Pandemic.
    Romatoski KS; Chung SH; Kenzik K; Rasic G; Ng SC; Tseng JF; Sachs TE
    J Am Coll Surg; 2023 Sep; 237(3):420-430. PubMed ID: 37227063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic factors and colorectal cancer incidence, stage and quality of care in Denmark during the COVID-19 pandemic.
    Weinberger Rosen A; Jensen H; Olesen TB; Møller H; Jensen JW; Gögenur I
    Cancer Epidemiol; 2023 Oct; 86():102447. PubMed ID: 37633057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
    Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
    Lou J; Kooragayala K; Williams JP; Sandilos G; Butchy MV; Yoon-Flannery K; Kwiatt M; Hong YK; Shersher DD; Burg JM
    Am J Clin Oncol; 2022 Sep; 45(9):381-390. PubMed ID: 35983965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada.
    Ramanakumar AV; Annie B; Frederic L; Christine B; Cathy R; Jean L
    Cancer Med; 2023 Mar; 12(5):6260-6269. PubMed ID: 36385491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Participation indicators of colorectal screenings in Hungary between 2008-2021].
    Kívés Z; Bódis J; Hunyady B; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Vajda R; Boncz I
    Magy Onkol; 2022 Oct; 66(3):209-217. PubMed ID: 36200501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.